Literature DB >> 26067090

A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.

Silvia Morbelli1, Valentina Garibotto, Elsmarieke Van De Giessen, Javier Arbizu, Gaël Chételat, Alexander Drezgza, Swen Hesse, Adriaan A Lammertsma, Ian Law, Sabina Pappata', Pierre Payoux, Marco Pagani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26067090     DOI: 10.1007/s00259-015-3098-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  47 in total

1.  Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

Authors:  G Chételat; B Desgranges; V de la Sayette; F Viader; F Eustache; J-C Baron
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

2.  Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

Authors:  K Herholz; E Salmon; D Perani; J C Baron; V Holthoff; L Frölich; P Schönknecht; K Ito; R Mielke; E Kalbe; G Zündorf; X Delbeuck; O Pelati; D Anchisi; F Fazio; N Kerrouche; B Desgranges; F Eustache; B Beuthien-Baumann; C Menzel; J Schröder; T Kato; Y Arahata; M Henze; W D Heiss
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

3.  Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project.

Authors:  Silvia Morbelli; Andrea Brugnolo; Irene Bossert; Ambra Buschiazzo; Giovanni B Frisoni; Samantha Galluzzi; Bart N M van Berckel; Rik Ossenkoppele; Robert Perneczky; Alexander Drzezga; Mira Didic; Eric Guedj; Gianmario Sambuceti; Gianluca Bottoni; Dario Arnaldi; Agnese Picco; Fabrizio De Carli; Marco Pagani; Flavio Nobili
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.

Authors:  Martina Bocchetta; Samantha Galluzzi; Patrick Gavin Kehoe; Eduardo Aguera; Roberto Bernabei; Roger Bullock; Mathieu Ceccaldi; Jean-François Dartigues; Alexandre de Mendonça; Mira Didic; Maria Eriksdotter; Olivier Félician; Lutz Frölich; Hermann-Josef Gertz; Merja Hallikainen; Steen G Hasselbalch; Lucrezia Hausner; Isabell Heuser; Frank Jessen; Roy W Jones; Alexander Kurz; Brian Lawlor; Alberto Lleo; Pablo Martinez-Lage; Patrizia Mecocci; Shima Mehrabian; Andreas Monsch; Flavio Nobili; Agneta Nordberg; Marcel Olde Rikkert; Jean-Marc Orgogozo; Florence Pasquier; Oliver Peters; Eric Salmon; Carmen Sánchez-Castellano; Isabel Santana; Marie Sarazin; Latchezar Traykov; Magda Tsolaki; Pieter Jelle Visser; Åsa K Wallin; Gordon Wilcock; David Wilkinson; Henrike Wolf; Görsev Yener; Dina Zekry; Giovanni B Frisoni
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

5.  Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.

Authors:  Paula T Trzepacz; Peng Yu; Jia Sun; Kory Schuh; Michael Case; Michael M Witte; Helen Hochstetler; Ann Hake
Journal:  Neurobiol Aging       Date:  2013-08-15       Impact factor: 4.673

6.  Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison.

Authors:  Anna Caroli; Annapaola Prestia; Kewei Chen; Napatkamon Ayutyanont; Susan M Landau; Cindee M Madison; Cathleen Haense; Karl Herholz; Flavio Nobili; Eric M Reiman; William J Jagust; Giovanni B Frisoni
Journal:  J Nucl Med       Date:  2012-02-17       Impact factor: 10.057

7.  Classification criteria for mild cognitive impairment: a population-based validation study.

Authors:  K Ritchie; S Artero; J Touchon
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

8.  Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.

Authors:  Il Han Choo; Ruiqing Ni; Michael Schöll; Anders Wall; Ove Almkvist; Agneta Nordberg
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.

Authors:  Chiara Cerami; Pasquale Anthony Della Rosa; Giuseppe Magnani; Roberto Santangelo; Alessandra Marcone; Stefano F Cappa; Daniela Perani
Journal:  Neuroimage Clin       Date:  2014-12-05       Impact factor: 4.881

10.  Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.

Authors:  Daniela Perani; Pasquale Anthony Della Rosa; Chiara Cerami; Francesca Gallivanone; Federico Fallanca; Emilia Giovanna Vanoli; Andrea Panzacchi; Flavio Nobili; Sabina Pappatà; Alessandra Marcone; Valentina Garibotto; Isabella Castiglioni; Giuseppe Magnani; Stefano F Cappa; Luigi Gianolli
Journal:  Neuroimage Clin       Date:  2014-10-24       Impact factor: 4.881

View more
  13 in total

1.  The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis.

Authors:  Silvia Morbelli; Javier Arbizu; Jan Booij; Ming-Kai Chen; Gael Chetelat; Donna J Cross; Mehdi Djekidel; Alexander Drzezga; Ozgul Ekmekcioglu; Valentina Garibotto; Swen Hesse; Kazunari Ishii; Lida Jafari; Adriaan A Lammertsma; Ian Law; Dana Mathews; Satoshi Minoshima; Karina Mosci; Marco Pagani; Sabina Pappata; Daniel Hillel Silverman; Alberto Signore; Elsmarieke Van De Giessen; Victor Villemagne; Henryk Barthel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-06       Impact factor: 9.236

2.  Validation of 18F-FDG-PET Single-Subject Optimized SPM Procedure with Different PET Scanners.

Authors:  Luca Presotto; Tommaso Ballarini; Silvia Paola Caminiti; Valentino Bettinardi; Luigi Gianolli; Daniela Perani
Journal:  Neuroinformatics       Date:  2017-04

3.  Dual-phase amyloid PET: hitting two birds with one stone.

Authors:  Garibotto Valentina; Morbelli Silvia; Pagani Marco
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-23       Impact factor: 9.236

Review 4.  Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia.

Authors:  Marina Boccardi; Cristina Festari; Daniele Altomare; Federica Gandolfo; Stefania Orini; Flavio Nobili; Giovanni B Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-30       Impact factor: 9.236

5.  18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.

Authors:  Silvia Morbelli; Matteo Bauckneht; Dario Arnaldi; Agnese Picco; Matteo Pardini; Andrea Brugnolo; Ambra Buschiazzo; Marco Pagani; Nicola Girtler; Alberto Nieri; Andrea Chincarini; Fabrizio De Carli; Gianmario Sambuceti; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-07       Impact factor: 9.236

6.  Controls-based denoising, a new approach for medical image analysis, improves prediction of conversion to Alzheimer's disease with FDG-PET.

Authors:  Dominik Blum; Inga Liepelt-Scarfone; Daniela Berg; Thomas Gasser; Christian la Fougère; Matthias Reimold
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-24       Impact factor: 9.236

Review 7.  Spatial normalization and quantification approaches of PET imaging for neurological disorders.

Authors:  Teng Zhang; Shuang Wu; Xiaohui Zhang; Yiwu Dai; Anxin Wang; Hong Zhang; Mei Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-28       Impact factor: 10.057

8.  Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.

Authors:  Lars Frings; Sabine Hellwig; Tobias Bormann; Timo S Spehl; Ralph Buchert; Philipp T Meyer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-15       Impact factor: 9.236

9.  Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?

Authors:  Stefan Teipel; Michel J Grothe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-10       Impact factor: 9.236

10.  The Alzheimer's disease metabolic brain pattern in mild cognitive impairment.

Authors:  Sanne K Meles; Marco Pagani; Dario Arnaldi; Fabrizio De Carli; Barbara Dessi; Silvia Morbelli; Gianmario Sambuceti; Cathrine Jonsson; Klaus L Leenders; Flavio Nobili
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.